Table 3.
Distribution of malignant lesions, SUVmax metrics and SUV ratios (n = 114).
| Lesions | Number | SUVmax early | SUVmax delay | △SUVmax | RI (%) | SUV ratio early | SUV ratio delay | Ratio (SUV ratio delay/early) |
|---|---|---|---|---|---|---|---|---|
| Primary lesion | 16 | 10.3 ± 5.4 | 13.3 ± 7.5 | 3.0 ± 2.6 | 25.7 ± 20.9 | 21.4 ± 10.8 | 34.6 ± 19.2 | 1.6 ± 0.4 |
| Metastatic lesions | 98 | 11.0 ± 13.3 | 14.9 ± 17.8 | 3.9 ± 4.1 | 66.4 ± 105.7 | 22.7 ± 28.0 | 33.1 ± 38.2 | 1.6 ± 0.7 |
| Local invasion | 9 | 9.5 ± 5.6 | 14.2 ± 9.2 | 4.7 ± 4.4 | 45.9 ± 41.4 | 16.0 ± 8.6 | 26.6 ± 15.9 | 1.7 ± 0.5 |
| Bone | 47 | 12.3 ± 13.4 | 16.3 ± 17.4 | 4.2 ± 4.4 | 59.2 ± 69.3 | 22.6 ± 25.0 | 33.2 ± 33.8 | 1.6 ± 0.8 |
| Lymph node | 38 | 10.5 ± 15.0 | 14.2 ± 20.4 | 3.74 ± 4.0 | 69.7 ± 140.8 | 20.8 ± 22.9 | 30.7 ± 33.2 | 1.6 ± 0.6 |
| other | 4 | 4.0 ± 2.8 | 4.8 ± 2.9 | 3.5 ± 2.0 | 164.8 ± 154.0 | 11.7 ± 14.2 | 14.4 ± 13.2 | 1.7 ± 0.6 |
| P value a | 0.823 | 0.725 | 0.416 | 0.001* | 0.859 | 0.880 | 0.763 | |
| P value b | 0.811 | 0.791 | 0.692 | 0.145 | 0.319 | 0.511 | 0.988 |
Values presented as mean ± SD or number.
aComparison of primary and metastatic lesions, independent sample T test was used analyze.
bComarison of malignant lesions in various parts, one-way ANOVA; * stands for significant difference between the groups (p < 0.05).